Industry: Medical Devices & Consumables
Published Date: 2025-06-04
Pages: 132 Pages
Report ld: 4753434
Request Sample
Customized Report
Protein-free Blocking Buffer Market Size(US$)

CAGR 2025-2031
5.5%
Market Size,2031
USD 674
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Protein-free Blocking Buffer was estimated to be worth US$ 466 million in 2024 and is forecast to a readjusted size of US$ 674 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Protein-free immune blocking solution is a blocking agent used in immunological experiments. It is mainly used to block nonspecific binding sites to prevent antibodies or other probes from binding to non-target sites on membranes or microplates, thereby improving the specificity and sensitivity of the experiment.
North American market for Protein-free Blocking Buffer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Protein-free Blocking Buffer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Protein-free Blocking Buffer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Protein-free Blocking Buffer include Meilunbio, Solarbio, Changzhou Boyi Biotechnology Co., Ltd., Shanghai Yamay Biomedical Technology Co., Ltd., Boster Biologica, Beijing Kang Runcheng Industry Biotechnology Co., Ltd., Life-ilab, Hubei Pumei Biotechnology Co., Ltd., Beijing Botes Biotechnology Co., Ltd., Biosharp, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Protein-free Blocking Buffer, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Protein-free Blocking Buffer by region & country, by Type, and by Application.
The Protein-free Blocking Buffer market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein-free Blocking Buffer.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Protein-free Blocking Buffer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Protein-free Blocking Buffer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Protein-free Blocking Buffer in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Protein-free Blocking Buffer Product Introduction
1.2 Global Protein-free Blocking Buffer Market Size Forecast (2020-2031)
1.3 Protein-free Blocking Buffer Market Trends & Drivers
1.3.1 Protein-free Blocking Buffer Industry Trends
1.3.2 Protein-free Blocking Buffer Market Drivers & Opportunity
1.3.3 Protein-free Blocking Buffer Market Challenges
1.3.4 Protein-free Blocking Buffer Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Protein-free Blocking Buffer Players Revenue Ranking (2024)
2.2 Global Protein-free Blocking Buffer Revenue by Company (2020-2025)
2.3 Key Companies Protein-free Blocking Buffer Manufacturing Base Distribution and Headquarters
2.4 Key Companies Protein-free Blocking Buffer Product Offered
2.5 Key Companies Time to Begin Mass Production of Protein-free Blocking Buffer
2.6 Protein-free Blocking Buffer Market Competitive Analysis
2.6.1 Protein-free Blocking Buffer Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Protein-free Blocking Buffer Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein-free Blocking Buffer as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 500ML
3.1.2 1000ML
3.2 Global Protein-free Blocking Buffer Sales Value by Type
3.2.1 Global Protein-free Blocking Buffer Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Protein-free Blocking Buffer Sales Value, by Type (2020-2031)
3.2.3 Global Protein-free Blocking Buffer Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 University
4.1.2 Laboratory
4.1.3 Hospital
4.1.4 Others
4.2 Global Protein-free Blocking Buffer Sales Value by Application
4.2.1 Global Protein-free Blocking Buffer Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Protein-free Blocking Buffer Sales Value, by Application (2020-2031)
4.2.3 Global Protein-free Blocking Buffer Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Protein-free Blocking Buffer Sales Value by Region
5.1.1 Global Protein-free Blocking Buffer Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Protein-free Blocking Buffer Sales Value by Region (2020-2025)
5.1.3 Global Protein-free Blocking Buffer Sales Value by Region (2026-2031)
5.1.4 Global Protein-free Blocking Buffer Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Protein-free Blocking Buffer Sales Value, 2020-2031
5.2.2 North America Protein-free Blocking Buffer Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Protein-free Blocking Buffer Sales Value, 2020-2031
5.3.2 Europe Protein-free Blocking Buffer Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Protein-free Blocking Buffer Sales Value, 2020-2031
5.4.2 Asia Pacific Protein-free Blocking Buffer Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Protein-free Blocking Buffer Sales Value, 2020-2031
5.5.2 South America Protein-free Blocking Buffer Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Protein-free Blocking Buffer Sales Value, 2020-2031
5.6.2 Middle East & Africa Protein-free Blocking Buffer Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Protein-free Blocking Buffer Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Protein-free Blocking Buffer Sales Value, 2020-2031
6.3 United States
6.3.1 United States Protein-free Blocking Buffer Sales Value, 2020-2031
6.3.2 United States Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Protein-free Blocking Buffer Sales Value, 2020-2031
6.4.2 Europe Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Protein-free Blocking Buffer Sales Value, 2020-2031
6.5.2 China Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.5.3 China Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Protein-free Blocking Buffer Sales Value, 2020-2031
6.6.2 Japan Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Protein-free Blocking Buffer Sales Value, 2020-2031
6.7.2 South Korea Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Protein-free Blocking Buffer Sales Value, 2020-2031
6.8.2 Southeast Asia Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Protein-free Blocking Buffer Sales Value, 2020-2031
6.9.2 India Protein-free Blocking Buffer Sales Value by Type (%), 2024 VS 2031
6.9.3 India Protein-free Blocking Buffer Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Meilunbio
7.1.1 Meilunbio Profile
7.1.2 Meilunbio Main Business
7.1.3 Meilunbio Protein-free Blocking Buffer Products, Services and Solutions
7.1.4 Meilunbio Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.1.5 Meilunbio Recent Developments
7.2 Solarbio
7.2.1 Solarbio Profile
7.2.2 Solarbio Main Business
7.2.3 Solarbio Protein-free Blocking Buffer Products, Services and Solutions
7.2.4 Solarbio Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.2.5 Solarbio Recent Developments
7.3 Changzhou Boyi Biotechnology Co., Ltd.
7.3.1 Changzhou Boyi Biotechnology Co., Ltd. Profile
7.3.2 Changzhou Boyi Biotechnology Co., Ltd. Main Business
7.3.3 Changzhou Boyi Biotechnology Co., Ltd. Protein-free Blocking Buffer Products, Services and Solutions
7.3.4 Changzhou Boyi Biotechnology Co., Ltd. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.3.5 Changzhou Boyi Biotechnology Co., Ltd. Recent Developments
7.4 Shanghai Yamay Biomedical Technology Co., Ltd.
7.4.1 Shanghai Yamay Biomedical Technology Co., Ltd. Profile
7.4.2 Shanghai Yamay Biomedical Technology Co., Ltd. Main Business
7.4.3 Shanghai Yamay Biomedical Technology Co., Ltd. Protein-free Blocking Buffer Products, Services and Solutions
7.4.4 Shanghai Yamay Biomedical Technology Co., Ltd. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.4.5 Shanghai Yamay Biomedical Technology Co., Ltd. Recent Developments
7.5 Boster Biologica
7.5.1 Boster Biologica Profile
7.5.2 Boster Biologica Main Business
7.5.3 Boster Biologica Protein-free Blocking Buffer Products, Services and Solutions
7.5.4 Boster Biologica Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.5.5 Boster Biologica Recent Developments
7.6 Beijing Kang Runcheng Industry Biotechnology Co., Ltd.
7.6.1 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Profile
7.6.2 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Main Business
7.6.3 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Protein-free Blocking Buffer Products, Services and Solutions
7.6.4 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.6.5 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Recent Developments
7.7 Life-ilab
7.7.1 Life-ilab Profile
7.7.2 Life-ilab Main Business
7.7.3 Life-ilab Protein-free Blocking Buffer Products, Services and Solutions
7.7.4 Life-ilab Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.7.5 Life-ilab Recent Developments
7.8 Hubei Pumei Biotechnology Co., Ltd.
7.8.1 Hubei Pumei Biotechnology Co., Ltd. Profile
7.8.2 Hubei Pumei Biotechnology Co., Ltd. Main Business
7.8.3 Hubei Pumei Biotechnology Co., Ltd. Protein-free Blocking Buffer Products, Services and Solutions
7.8.4 Hubei Pumei Biotechnology Co., Ltd. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.8.5 Hubei Pumei Biotechnology Co., Ltd. Recent Developments
7.9 Beijing Botes Biotechnology Co., Ltd.
7.9.1 Beijing Botes Biotechnology Co., Ltd. Profile
7.9.2 Beijing Botes Biotechnology Co., Ltd. Main Business
7.9.3 Beijing Botes Biotechnology Co., Ltd. Protein-free Blocking Buffer Products, Services and Solutions
7.9.4 Beijing Botes Biotechnology Co., Ltd. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.9.5 Beijing Botes Biotechnology Co., Ltd. Recent Developments
7.10 Biosharp
7.10.1 Biosharp Profile
7.10.2 Biosharp Main Business
7.10.3 Biosharp Protein-free Blocking Buffer Products, Services and Solutions
7.10.4 Biosharp Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.10.5 Biosharp Recent Developments
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Profile
7.11.2 Thermo Fisher Scientific Main Business
7.11.3 Thermo Fisher Scientific Protein-free Blocking Buffer Products, Services and Solutions
7.11.4 Thermo Fisher Scientific Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.11.5 Thermo Fisher Scientific Recent Developments
7.12 Applygen
7.12.1 Applygen Profile
7.12.2 Applygen Main Business
7.12.3 Applygen Protein-free Blocking Buffer Products, Services and Solutions
7.12.4 Applygen Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.12.5 Applygen Recent Developments
7.13 Yoche Biotechnology
7.13.1 Yoche Biotechnology Profile
7.13.2 Yoche Biotechnology Main Business
7.13.3 Yoche Biotechnology Protein-free Blocking Buffer Products, Services and Solutions
7.13.4 Yoche Biotechnology Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.13.5 Yoche Biotechnology Recent Developments
7.14 Servicebio
7.14.1 Servicebio Profile
7.14.2 Servicebio Main Business
7.14.3 Servicebio Protein-free Blocking Buffer Products, Services and Solutions
7.14.4 Servicebio Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.14.5 Servicebio Recent Developments
7.15 Ecotopbio
7.15.1 Ecotopbio Profile
7.15.2 Ecotopbio Main Business
7.15.3 Ecotopbio Protein-free Blocking Buffer Products, Services and Solutions
7.15.4 Ecotopbio Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.15.5 Ecotopbio Recent Developments
7.16 LI-COR Biotech
7.16.1 LI-COR Biotech Profile
7.16.2 LI-COR Biotech Main Business
7.16.3 LI-COR Biotech Protein-free Blocking Buffer Products, Services and Solutions
7.16.4 LI-COR Biotech Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.16.5 LI-COR Biotech Recent Developments
7.17 Geno Technology Inc.
7.17.1 Geno Technology Inc. Profile
7.17.2 Geno Technology Inc. Main Business
7.17.3 Geno Technology Inc. Protein-free Blocking Buffer Products, Services and Solutions
7.17.4 Geno Technology Inc. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.17.5 Geno Technology Inc. Recent Developments
7.18 Visual Protein
7.18.1 Visual Protein Profile
7.18.2 Visual Protein Main Business
7.18.3 Visual Protein Protein-free Blocking Buffer Products, Services and Solutions
7.18.4 Visual Protein Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.18.5 Visual Protein Recent Developments
7.19 Azure Biosystems Inc.
7.19.1 Azure Biosystems Inc. Profile
7.19.2 Azure Biosystems Inc. Main Business
7.19.3 Azure Biosystems Inc. Protein-free Blocking Buffer Products, Services and Solutions
7.19.4 Azure Biosystems Inc. Protein-free Blocking Buffer Revenue (US$ Million) & (2020-2025)
7.19.5 Azure Biosystems Inc. Recent Developments
8 Industry Chain Analysis
8.1 Protein-free Blocking Buffer Industrial Chain
8.2 Protein-free Blocking Buffer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Protein-free Blocking Buffer Sales Model
8.5.2 Sales Channel
8.5.3 Protein-free Blocking Buffer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Protein-free Blocking Buffer market is projected to grow from US$ 489 million in 2025 to US$ 708 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 147
USD 4900.00
(Single User License)
The global Protein-free Blocking Buffer market size was US$ 489 million in 2025 and is forecast to reach a readjusted size of US$ 708 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 109
USD 4250.00
(Single User License)
The global market for Protein-free Blocking Buffer was estimated to be worth US$ 489 million in 2025 and is projected to reach US$ 708 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 121
USD 3950.00
(Single User License)
The global Protein-free Blocking Buffer market was valued at US$ 489 million in 2025 and is anticipated to reach US$ 708 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 135
USD 2900.00
(Single User License)
The global Protein-free Blocking Buffer market size was US$ 466 million in 2024 and is forecast to a readjusted size of US$ 674 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 103
USD 4250.00
(Single User License)
The global market for Protein-free Blocking Buffer was valued at US$ 466 million in the year 2024 and is projected to reach a revised size of US$ 674 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-06-04
Pages: 94
USD 2900.00
(Single User License)
The global Protein-free Blocking Buffer market is projected to grow from US$ 489 million in 2025 to US$ 674 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Published Date: 2025-06-04
Pages: 150
USD 4900.00
(Single User License)
The global Protein-free Blocking Buffer market is projected to grow from US$ 489 million in 2025 to US$ 708 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 147
The global Protein-free Blocking Buffer market size was US$ 489 million in 2025 and is forecast to reach a readjusted size of US$ 708 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 109
The global market for Protein-free Blocking Buffer was estimated to be worth US$ 489 million in 2025 and is projected to reach US$ 708 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 121
The global Protein-free Blocking Buffer market was valued at US$ 489 million in 2025 and is anticipated to reach US$ 708 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 135
The global Protein-free Blocking Buffer market size was US$ 466 million in 2024 and is forecast to a readjusted size of US$ 674 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 103
The global market for Protein-free Blocking Buffer was valued at US$ 466 million in the year 2024 and is projected to reach a revised size of US$ 674 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-06-04
Pages: 94
The global Protein-free Blocking Buffer market is projected to grow from US$ 489 million in 2025 to US$ 674 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Published: 2025-06-04
Pages: 150
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now